Acquiring Company
Jazz Pharmaceuticals plc
Acquired Company
Actio Biosciences
San DiegoManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaBiotechnologyHealth CareTherapeuticsDescription
Jazz Pharmaceuticals has announced its acquisition of Actio Biosciences for $820 million upfront, with additional contingent payments of up to $500 million. This strategic move enhances Jazz's rare epilepsy portfolio, particularly focusing on the clinical asset ABS-1230 for KCNT1+ epilepsy. The acquisition emphasizes Jazz's commitment to addressing significant patient needs in the epilepsy community.
Quick answer
Jazz Pharmaceuticals plc is acquiring Actio Biosciences, announced August 10, 2026.
- How much did Jazz Pharmaceuticals plc pay for Actio Biosciences?
- The deal value was not disclosed.
- What does Jazz Pharmaceuticals plc do?
- Jazz Pharmaceuticals plc is a global biopharmaceutical company dedicated to developing life-changing medicines for people with limited or no options.
- Where are Jazz Pharmaceuticals plc and Actio Biosciences based?
- Actio Biosciences is based in San Diego, California, United States.
- Who are the decision-makers at Jazz Pharmaceuticals plc?
- Fundz holds 1 contact at Jazz Pharmaceuticals plc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals (August 6, 2026)
- Tarsus acquires iRenix Medical for IRX-101 development (July 8, 2026)
- Bristol-Myers acquires Medarex for cancer pipeline (August 2, 2026)
- Aurinia completes acquisition of Kezar Life Sciences (August 29, 2026)
- Bora Pharmaceuticals acquires MacroGenics' operations (July 2, 2026)
- Supernus to merge with Indivior Pharmaceuticals (August 3, 2026)
Who to call at Jazz Pharmaceuticals plc, and when
When Jazz Pharmaceuticals plc changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Jazz Pharmaceuticals plc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Jazz Pharmaceuticals plc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Jazz Pharmaceuticals plc. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Jazz Pharmaceuticals plc makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Actio Biosciences?
Actio Biosciences was acquired by Jazz Pharmaceuticals plc. The deal was reported on August 10, 2026. Jazz Pharmaceuticals plc is a global biopharmaceutical company dedicated to developing life-changing medicines for people with limited or no options. Jazz Pharmaceuticals plc is publicly traded (JAZZ) and operates in Manufacturing.
When did Jazz Pharmaceuticals plc acquire Actio Biosciences?
Jazz Pharmaceuticals plc's acquisition of Actio Biosciences was reported on August 10, 2026. Jazz Pharmaceuticals has announced its acquisition of Actio Biosciences for $820 million upfront, with additional contingent payments of up to $500 million. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Actio Biosciences do?
Actio Biosciences is a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases. It is privately held, operating in Biotechnology, and is based in San Diego.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.